A new device appears to be a safe and effective tool for treating recurrent corneal erosions and other corneal issues, according to a study.
Conducted with 45 patients suffering from various corneal pathologies, the IRB-approved study aimed to assess the safety of the plexitome device. The procedure involved using the device either through loose epithelial tissue or after debridement with a cotton tip. Following treatment, patients received standard care, including topical medications and bandage contact lenses.
Results from the study were promising. The plexitome did not produce visible scarring in the corneal stroma of any patient. Notably, only 1 patient showed minor imprinting at the 30-day follow-up, with no significant adverse events reported.
The findings suggest that the plexitome could offer a safer, scar-free alternative for treating recurrent corneal erosions and other corneal conditions, especially in the optical axis where traditional methods are less effective. Further research and follow-up studies will be essential to confirm these results and establish long-term efficacy.
Reference
Chaum E, Kim DB, Kane S, et al. Pilot Safety Study of a Microfabricated Device for Anterior Stromal Puncture to Treat Corneal Epithelial Disease in the Optical Axis. Cornea. 2024;doi: 10.1097/ICO.0000000000003651. Epub ahead of print. PMID: 39085991.
Related Content
